Loading company…
Riskpilot
← Back to search
Sign in
Get full access
CBC Microbiology AB
AB
Bankrupt
Org 5591963466
Economic activity was not specified by tax authority · NACE 0000
Est. 2019
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2020
SEK 0
EBITDA margin
—
+91% vs 2019
Equity ratio
100.0%
Financial strength
Net profit 2020
SEK -1K
+91% vs 2019
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
Key figures
Annual report 2020
Revenue
SEK 0
—
EBITDA
SEK -1K
+91%
Net profit
SEK -1K
+91%
Total assets
SEK 3,7M
+0%
Equity
SEK 3,7M
+0%
Employees
0
—
Company information
Legal name
CBC Microbiology AB
Org number
5591963466
Legal form
Aktiebolag
NACE code
0000 · Economic activity was not specified by tax authority
Founded
25 februari 2019
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva holdingverksamhet i mikrobiologirelaterade bolag och därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Economic activity was not specified by tax authority
Companies in Göteborg
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
Income statement
SEK thousands
Item
2019
2020
Revenue
0
0
Staff expenses
—
—
EBITDA
−11
−1
Depreciation & amort.
−0
−0
EBIT
−11
−1
Net financials
—
—
Profit before tax
−11
−1
Tax
−0
−0
Net profit
−11
−1
Balance sheet
SEK thousands
Item
2019
2020
Total assets
3 745
3 744
Equity
3 745
3 744
Long-term debt
0
0
Short-term debt
0
0
Total debt
—
—
Financial ratios
5-year trend
EBITDA margin
-100000.0%
This company
15.8%
Market median
-633011% vs market
2019
2020
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2019
2020
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
2019
2020
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
2019
2020
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2020
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2019
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-02-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PT
Per Tage Fridén
Liquidator
Liquidator
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
EA
Ester Ann Christin Velander
Deputy Board Member
2020 – 2022
AM
Ana Margarida Correia Palmlöf
Deputy Board Member
2022 – 2022
TG
Thomas Gottfrid Palmlöv
Deputy Board Member
2022 – 2024
NA
Niklas Anders Palmlöv
Board of Directors
2020 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of CBC Microbiology AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Tage Fridén
Liquidator
0 companies
Ester Ann Christin Velander
Deputy Board Member
0 companies
Ana Margarida Correia Palmlöf
Deputy Board Member
0 companies
Thomas Gottfrid Palmlöv
Deputy Board Member
0 companies
Niklas Anders Palmlöv
Board of Directors
0 companies